Celyad Oncology Appoints Georges Rawadi as New CEO – Celyad…
MONT-SAINT-GUIBERT, Belgium, March 24, 2023 (GLOBE NEWSWIRE) – Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the “Company”), a biotechnology company focused on innovative technologies for Chimeric Antigen